The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs

被引:28
|
作者
Schwebel, Herve J. [1 ]
van Hoogevest, Peter [1 ]
Leigh, Mathew L. S. [1 ]
Kuentz, Martin [2 ]
机构
[1] Phares AG, Muttenz, Switzerland
[2] Univ Appl Sci NW Switzerland, Inst Pharma Technol, CH-4132 Muttenz, Switzerland
关键词
Poorly soluble drugs; biorelevant media; FeSSIF; FaSSIF; apparent solubilizing capacity; BIORELEVANT DISSOLUTION MEDIA; HUMAN GASTROINTESTINAL-TRACT; BILE-SALT; FENOFIBRATE; FORMULATION; ABSORPTION; BIOAVAILABILITY; PREDICTION; LECITHIN; MICELLE;
D O I
10.3109/10837451003664099
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug solubility testing in biorelevant media has become an indispensable tool in pharmaceutical development. Despite this importance, there is still an incomplete understanding of how poorly soluble compounds interact with these media. The aim of this study was to apply the concept of the apparent solubilization capacity to fasted and fed state simulated intestinal fluid (FaSSIF and FeSSIF, respectively). A set of non-ionized poorly soluble compounds was studied in biorelevant media prepared from an instantly dissolving complex (SIF (TM) Powder) at 37 degrees C. The values of the solubilization capacity were different between FaSSIF and FeSSIF but correlated. Drug inclusion into the mixed micelles was highly specific for a given compound. The ratio of the FeSSIF to FaSSIF solubility was in particular considered and discussed in terms of the apparent solubilizing capacity. The apparent solubilization concept appears to be useful for the interpretation of biorelevant solubility tests. Further studies are needed to explore acidic and basic drugs.
引用
收藏
页码:278 / 286
页数:9
相关论文
共 50 条
  • [21] Fluorescence investigation of a specific structure formed by aggregation of transglycosylated stevias: Solubilizing effect of poorly water-soluble drugs
    Uchiyama, Hiromasa
    Tozuka, Yuichi
    Asamoto, Fusatoshi
    Takeuchi, Hirofumi
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 43 (1-2) : 71 - 77
  • [22] An Intestinal "Transformers"-like Nanocarrier System for Enhancing the Oral Bioavailability of Poorly Water-Soluble Drugs
    Chuang, Er-Yuan
    Lin, Kun-Ju
    Huang, Tring-Yo
    Chen, Hsin-Lung
    Miao, Yang-Bao
    Lin, Po-Yen
    Chen, Chiung-Tong
    Juang, Jyuhn-Huarng
    Sung, Hsing-Wen
    ACS NANO, 2018, 12 (07) : 6389 - 6397
  • [23] Molecular Interactions in Solid Dispersions of Poorly Water-Soluble Drugs
    Tran, Thao T. D.
    Tran, Phuong H. L.
    PHARMACEUTICS, 2020, 12 (08) : 1 - 12
  • [24] Solubilization of poorly water-soluble drugs by hydroxybutenyl cyclodextrins.
    Buchanan, CM
    Buchanan, NL
    Jicsinszky, L
    Posey-Dowty, J
    Szejtli, J
    Szente, L
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U241 - U242
  • [25] Pharmaceutical Methods for Enhancing the Dissolution of Poorly Water-Soluble Drugs
    Mahmood, Tahir
    Sarfraz, Rai M. M.
    Ismail, Asmara
    Ali, Muhammad
    Khan, Abdur Rauf
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023, 21 (02) : 65 - 79
  • [26] Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs
    Junyaprasert, Varaporn Buraphacheep
    Morakul, Boontida
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 10 (01) : 13 - 23
  • [27] A review on solubility enhancement methods for poorly water-soluble drugs
    Ainurofiq, Ahmad
    Putro, David Sarono
    Ramadhani, Dhea Aqila
    Putra, Gemala Mahendra
    Santo, Laura Da Costa Do Espirito
    JOURNAL OF REPORTS IN PHARMACEUTICAL SCIENCES, 2021, 10 (01): : 137 - 147
  • [28] DISSOLUTION KINETICS OF POORLY WATER-SOLUBLE DRUGS IN MICELLAR SOLUTIONS
    DESMIDT, JH
    OFFRINGA, JCA
    RUTGERS, AAL
    CROMMELIN, DJA
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1985, 7 (02) : 92 - 92
  • [29] Novel strategies for the formulation and processing of poorly water-soluble drugs
    Goeke, Katrin
    Lorenz, Thomas
    Repanas, Alexandros
    Schneider, Frederic
    Steiner, Denise
    Baumann, Knut
    Bunjes, Heike
    Dietzel, Andreas
    Finke, Jan H.
    Glasmacher, Birgit
    Kwade, Arno
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 126 : 40 - 56